Earnings call transcript: UiPath Q1 2026 beats expectations, shares jump

UiPath (PATH) reported strong Q1 fiscal 2026 results, exceeding expectations with an EPS of $0.11 (vs. $0.10 forecast) and revenue of $357 million (vs. $332.83 million expected), driving a 9.35% after-hours stock surge to $14.15. The company's ARR reached $1.693 billion, up 12% year-over-year, and management highlighted strategic partnerships and product innovations, particularly around their Agentic Automation platform, which is expected to contribute significantly to revenue in fiscal 2027. For Q2 fiscal 2026, UiPath projects revenue between $345 million and $350 million and full-year revenue guidance at $1.549 billion to $1.554 billion.

Analysis

UiPath Inc. (PATH) reported a robust first-quarter fiscal 2026, exceeding analyst consensus with an earnings per share of $0.11 against a $0.10 forecast and revenue of $357 million, surpassing the anticipated $332.83 million. This performance, representing a 6% year-over-year revenue increase, was driven by Annual Recurring Revenue (ARR) reaching $1.693 billion, up 12% from the prior year, and strong operational metrics including an 83% gross profit margin and $117 million in non-GAAP adjusted free cash flow. The positive results triggered a 9.35% surge in PATH's stock in after-hours trading. Management has designated fiscal 2026 as a "foundational year" for its new Agentic Automation platform, with early adoption indicators such as over 250,000 agent runs via AgentBuilder and more than 11,000 process instances powered by Maestro, anticipating significant revenue contributions from this platform in fiscal 2027. The company's financial health, rated as "GOOD" by InvestingPro which also suggests the stock appears undervalued, is further underscored by a $1.6 billion cash position and the repurchase of 21.9 million shares at an average price of $10.40 during the quarter. While Q2 FY26 revenue guidance is set between $345 million and $350 million, and full-year revenue between $1.549 billion and $1.554 billion, reflecting a prudent outlook on the immediate revenue impact from new agentic solutions, the long-term strategy appears focused. Strategic initiatives including partnerships with Google Cloud for healthcare AI solutions, expanded collaboration with Microsoft CoPilot Studio, and customer wins like Delta Airlines and the U.S. Air Force, alongside product innovations such as Intelligent Extraction Processing (iXP), underpin this growth narrative. However, the company acknowledges risks from macroeconomic uncertainty and competitive pressures.

Key Decisions for Investors

• Investors should consider the strong Q1 FY26 performance, InvestingPro's assessment of potential undervaluation and 'GOOD' financial health score, and management's share buyback activity as positive indicators, while noting that near-term revenue contribution from new agentic platforms is guided conservatively for FY26.
• Closely monitor the adoption trajectory and monetization success of the Agentic Automation platform, including Maestro and AgentBuilder, as these are pivotal for achieving the projected significant revenue growth in fiscal 2027 and beyond.
• Evaluate the progress of strategic partnerships (e.g., Google Cloud, Microsoft, Deloitte) and the rate of new enterprise customer acquisitions, particularly competitive displacements, as key validation points for UiPath's platform differentiation and market leadership in AI-driven automation.
• Remain cognizant of stated risks such as macroeconomic headwinds, intense competition in the AI and automation sectors, and the need for continuous technological innovation, which could impact future growth despite the current positive momentum.